Home › Forums › Infexion Connexion › 3M Webinar: 2021 Infusion Therapy Standards of Practice – Reducing CABSI Risk: People, Standards and Technology
- This topic has 0 replies, 1 voice, and was last updated 3 years ago by ACIPC Office.
-
AuthorPosts
-
21/07/2021 at 10:59 am #78213
(sponsored content)
Dear ACIPC Members,
3M have an upcoming webinar that may be of interest on 4th August 2021 @ 3pm-430pm EAST.
Moderator for Q&A session: Tricia Kleidon
Registration link:
https://attendee.gotowebinar.com/register/291153294197095183?sourceACIPC_EduReducing CABSI Risk: People, Standards and
Technology – Part 3 of 5.Recognised as the premier organisation for the specialty practice of infusion nursing, the Infusion Nursing
Society (INS) released the 2021 Infusion Therapy Standards of Practice in January 2021. Join us for the third
webinar in our five-part series aimed at translating these standards into practise.
In this webinar, Dr Britt Meyer will update on the key standards to reduce CABSI risk. The webinar will be
moderated by Tricia Kleidon, a Nurse Practitioner in the Vascular Assessment and Management Service at
Queensland Children’s Hospital, Research Fellow at Griffith University and an active member of the
AVATAR groupObjectives:
* Identify sources of contamination that can lead to catheter associated bloodstream infection (CABSI)
* Discuss clinical challenges associated with catheter maintenance that can impact outcomes
* Describe recommended standards of practice, guidelines, and evidence-based interventions for catheter maintenance to reduce CABSI risk
* Identify solutions to address these challenges and clinical studies that support these solutionsSpeaker Bio:
Dr Britt Meyer is a Duke University School of Nursing Quality Implementation Scholar
who provides leadership for vascular access and infusion practices at Duke University
Health System. She leads the 55-member vascular access team at Duke University
Hospital and is widely published on vascular access and infusion topics. She is currently
involved in a variety of research projects aimed at improving patient outcomes related
to vascular access and infusion therapy.MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.
The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au
To send a message to the list administrator send an email to admin@acipc.org.au
You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au
-
AuthorPosts
- The forum ‘Infexion Connexion’ is closed to new topics and replies.